Last updated on October 2018

Safety and Efficacy Study of Filgotinib GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome

Brief description of study

The primary objective of this study is to assess the efficacy of filgotinib, GS-9876, and tirabrutinib (formerly GS-4059) in adults with active Sjogren's Syndrome (SjS).

Clinical Study Identifier: NCT03100942

Contact Investigators or Research Sites near you

Start Over

Gilead Clinical Study Information Center

Centrum Medyczne Oporow
Wroclaw, Poland

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.